Opioid use after hip and knee replacement

Persistent Opioid Use after Hip and Knee Arthroplasty: A Retrospective cohort study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12619000446167

Enrollment

Registered

2019-03-19

Start date

2017-07-01

Completion date

2017-10-31

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Opioids are an important tool in the management of pain and the benefits are well understood. However, opioids for some patients, may also have a detrimental influence on how much benefit you get from your joint replacement surgery. This is the subject of ongoing research. In this study we would like to gain a better understanding on the taking of opioid medications both before and after joint replacement surgery.

Interventions

Consecutive patients who underwent unilateral primary total hip replacement or total knee replacement were invited to participate in the survey 3 months post-surgery. This survey was designed by a panel of experienced clinicians (an anaesthetist, 2 surgeons, a nurse and a physiotherapist) and consisted of 10 multiple-choice questions, and 1 free text response. The survey was sent via email or post 3 months post operatively. Patients were provided a reference list of common opioids to help identi

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

• Age greater than 18 at the time of surgery • Unilateral THA or TKA surgery • The individual is capable of understanding the questionnaire and responding in English

Exclusion criteria

• Revision or bilateral joint replacement • Significant pain-related illness within 3 months following surgery • Further surgical procedures in the 3 months after joint replacement that requires prescription opioids

Outcome results